CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Share buybacks
- Total buybacks · last 12 months (USD): Value $324.07M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-27..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-27..
Share buybacks
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $324.07M | Trailing-year cash paid for share repurchases. Period ending 2026-06-27. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-27. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 324.07M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-27 | $324.07M | (m) | (m) |
| 2026-03-28 | $215.83M | (m) | (m) |
| 2025-12-27 | $360.67M | (m) | (m) |
| 2025-09-27 | $360.70M | (m) | (m) |
| 2025-06-28 | $461.39M | (m) | (m) |
| 2025-03-29 | $462.96M | (m) | (m) |
| 2024-12-28 | $119.17M | (m) | (m) |
| 2024-09-28 | $119.19M | (m) | (m) |
| 2024-06-29 | $18.44M | (m) | (m) |
| 2024-03-30 | $14.49M | (m) | (m) |
| 2023-12-30 | $24.16M | (m) | (m) |
| 2023-09-30 | $24.18M | (m) | (m) |
| 2023-07-01 | $24.16M | (m) | (m) |
| 2023-04-01 | $23.67M | (m) | (m) |
| 2022-12-31 | $38.65M | (m) | (m) |
| 2022-09-24 | $38.76M | (m) | (m) |
| 2022-06-25 | $38.88M | (m) | (m) |
| 2022-03-26 | $38.67M | (m) | (m) |
| 2021-12-25 | $40.71M | (m) | (m) |
| 2021-09-25 | $40.51M | (m) | (m) |
| 2021-06-26 | $40.48M | (m) | (m) |
| 2021-03-27 | $36.33M | (m) | (m) |
| 2020-12-26 | $23.98M | (m) | (m) |
| 2020-09-26 | $23.95M | (m) | (m) |
| 2020-06-27 | $24.00M | (m) | (m) |
| 2020-03-28 | $24.00M | (m) | (m) |
| 2019-12-28 | $18.09M | (m) | (m) |
| 2019-09-28 | $18.09M | (m) | (m) |
| 2019-06-29 | $18.06M | (m) | (m) |
| 2019-03-30 | $18.06M | (m) | (m) |
| 2018-12-29 | $13.85M | (m) | (m) |
| 2018-09-29 | $13.80M | (m) | (m) |
| 2018-06-30 | $49.76M | (m) | (m) |
| 2018-03-31 | $72.28M | (m) | (m) |
| 2017-12-30 | $106.91M | (m) | (m) |
| 2017-09-30 | $106.94M | (m) | (m) |
| 2017-07-01 | $70.89M | (m) | (m) |
| 2017-04-01 | $48.30M | (m) | (m) |
| 2016-12-31 | $12.27M | (m) | (m) |
| 2016-09-24 | $12.27M | (m) | (m) |
| 2016-06-25 | $30.19M | (m) | (m) |
| 2016-03-26 | $70.99M | (m) | (m) |
| 2015-12-26 | $117.48M | (m) | (m) |
| 2015-09-26 | $117.46M | (m) | (m) |
| 2015-06-27 | $119.89M | (m) | (m) |
| 2015-03-28 | $159.84M | (m) | (m) |
| 2014-12-27 | $122.02M | (m) | (m) |
| 2014-09-27 | $196.21M | (m) | (m) |
| 2014-06-28 | $240.64M | (m) | (m) |
| 2014-03-29 | $175.51M | (m) | (m) |
| 2013-12-28 | $165.93M | (m) | (m) |
| 2013-09-28 | $110.05M | (m) | (m) |
| 2013-06-29 | $60.27M | (m) | (m) |
| 2013-03-30 | $60.17M | (m) | (m) |
| 2012-12-29 | $64.19M | (m) | (m) |
| 2012-09-29 | $74.03M | (m) | (m) |
| 2012-06-30 | $123.50M | (m) | (m) |
| 2012-03-31 | $124.58M | (m) | (m) |
| 2011-12-31 | $283.80M | (m) | (m) |
| 2011-09-24 | $255.72M | (m) | (m) |
| 2011-06-25 | $544.67M | (m) | (m) |
| 2011-03-26 | $528.10M | (m) | (m) |
| 2010-12-25 | $356.53M | (m) | (m) |
| 2010-09-25 | (m) | (m) | (m) |
| 2010-06-26 | (m) | (m) | (m) |
| 2010-03-27 | (m) | (m) | (m) |
| 2009-12-26 | $45.90M | (m) | (m) |
| 2009-09-26 | (m) | (m) | (m) |
| 2009-06-27 | (m) | (m) | (m) |
| 2008-12-27 | $115.06M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |